Fully percutaneous vs. surgical transfemoral TAVR: similar major vascular complications rate and shorter hospital stay.

Original title: Factors associated with vascular complications in patients undergoing balloon-expandable transfemoral transcatheter aortic valve replacement via open versus percutaneous approaches. Reference: Kadakia MB et al. Circ Cardiovasc Interv. 2014; Epub ahead of print.

 

This retrospective study included 331 patients undergoing transfemoral TAVR in one center between 2007 and 2013. 64% of the population were treated with the fully percutaneous approach and the rest via the open surgical approach. Only the Edwards valve was employed (Sapien o Sapien XT).

At baseline, patients in the open surgical group presented major heart disease, previous infarction, chronic renal failure, worse functional class and higher STS score (11.1 vs 9.1; p=0.007). Those treated with fully percutaneous approach presented shorter length of stay (7.7 vs 9.9 days; p=0.003) and fewer vascular complications at 30 days (11% vs 20%: p=0.03).

The most common complications in both groups were iliofemoral perforation and iliofemoral dissection. There was no difference in all-cause in-hospital mortality between the groups.

After propensity score matching, on account of the different baseline characteristics, each group had 112 patients. The difference in major vascular complications disappeared (13% vs 15%; p=0.7) but the advantage of the fully percutaneous approach as regards hospital stay length remained (7.9 ± 5.5 days vs 10.0 ± 10.1; p=0.04).

The multivariable analysis showed 2 predictors of overall vascular complications: female sex (OR 2.2; IC 95% 1.1 a 4.3) and sheath oversizing (per 1 mm increase in the difference between sheath outer diameter and minimal artery diameter; OR 1.4; IC 95% 1.1 to 1.8).

Conclusion

Fully percutaneous TAVR was associated with a similar vascular complications risk and a significant shorter hospital stay compared to open surgical TAVR. Sheath oversizing (with respect to artery diameter), and female sex were associated to vascular complications, despite the approach.

Editorial Comment

Technological advances will continue to reduce sheath size, which in turn will reduce vascular complications. However, in the individual patient, outcomes will depend on careful planning, since sheath oversizing is the strongest predictor of vascular complications. 

A shorter hospital stay and a similar vascular complications rate makes the percutaneous approach the ideal technique; however, closure device cost vs. hospital cost should always be pondered on account of the different contexts in different countries. 

SOLACI.ORG

More articles by this author

Long Term Results of the International Chimney Registry

The International Chimney Registry was an observational study aimed at assessing the use of chimney stenting during TAVR either to predict or treat coronary...

CANNULATE TAVR extended study: Impact of Commissural and Coronary Alignment in Coronary Cannulation Following TAVR with Evolut Fx

The new valve Evolut FX has shown better commissural alignment vs. its predecessor Evolut Pro+. Prior studies have already shown commissure alignment facilitates post...

TRISCEND II: Transcatheter Replacement vs. Medical Treatment for Tricuspid Regurgitation

The EVOQUE device is designed with an intra-annular sealing system that provides excellent anatomical compatibility and an adaptable shape. It is currently available in...

J-Valve for Chronic AR: 30-Day Outcomes of Transfemoral Valve J-Valve in Chronic Aortic Regurgitation

Chronic aortic regurgitation (AR) poses a significant challenge as far as transcatheter alternatives go due to the absence of calcification and a suitable anchoring...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img

Recent Articles

Long Term Results of the International Chimney Registry

The International Chimney Registry was an observational study aimed at assessing the use of chimney stenting during TAVR either to predict or treat coronary...

CANNULATE TAVR extended study: Impact of Commissural and Coronary Alignment in Coronary Cannulation Following TAVR with Evolut Fx

The new valve Evolut FX has shown better commissural alignment vs. its predecessor Evolut Pro+. Prior studies have already shown commissure alignment facilitates post...

TRISCEND II: Transcatheter Replacement vs. Medical Treatment for Tricuspid Regurgitation

The EVOQUE device is designed with an intra-annular sealing system that provides excellent anatomical compatibility and an adaptable shape. It is currently available in...